Skip to main content
. 2012 Aug 31;34(12):886–893. doi: 10.1093/eurheartj/ehs262

Figure 3.

Figure 3

Angiotensin receptor blockade with neutral endopeptidase inhibition effects: decreased blood pressure as a result of the direct antihypertrophic, anti-fibrotic, endothelial, and renal-enhancing actions mediated by increased biological activities of the natriuretic peptides and by increased angiotensin type 2 receptor binding (adapted from Ruilope et al.,101 Copyright 2010, with permission from Elsevier).